Phosphatonins: a new class of phosphate-regulating proteins
- 1 July 2002
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Nephrology and Hypertension
- Vol. 11 (4) , 423-430
- https://doi.org/10.1097/00041552-200207000-00009
Abstract
There is an intimate relationship between phosphate and calcium homeostasis throughout the animal kingdom. One traditional assumption is that all phosphate-regulating hormones are primarily calcium-regulating hormones. Although the notion of a circulating substance dedicated to phosphate homeostasis has existed for more than a decade, it is not until recently that these hormones have been identified. The molecular characterization of these substances will prove to be critical for understanding phosphate physiology and clinical disorders of phosphate metabolism. This review will focus primarily on the first two proteins recently shown to have phosphatonin properties. Using three human diseases as models and a combination of positional cloning and differential gene expression, fibroblast growth factor 23 and frizzled-related protein 4 were shown to be associated with one or more of these diseases. Although both of these substances have phosphaturic action, their biological effects are likely to extend beyond epithelial phosphate transport. The phosphatonins are a growing family of substances that may act on multiple organs in autocrine, paracrine, and endocrine modes to regulate phosphate metabolism. As this list expands, the need for a more rigid definition of the term phosphatonin becomes evident. The identification and characterization of these phosphate-regulatory compounds will provide a clearer understanding of how individual phosphatonins regulate phosphate in normal and disease physiology.Keywords
This publication has 54 references indexed in Scilit:
- Autosomal-dominant hypophosphatemic rickets (ADHR) mutations stabilize FGF-23Kidney International, 2001
- A case of neuroendocrine oncogenic osteomalacia associated with a PHEX and fibroblast growth factor-23 expressing sinusidal malignant schwannomaBone, 2001
- Analysis of recombinant Phex: an endopeptidase in search of a substrateAmerican Journal of Physiology-Endocrinology and Metabolism, 2001
- FGF-23 Inhibits Renal Tubular Phosphate Transport and Is a PHEX SubstrateBiochemical and Biophysical Research Communications, 2001
- Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalaciaProceedings of the National Academy of Sciences, 2001
- Characterization of PHEX endopeptidase catalytic activity: identification of parathyroid-hormone-related peptide107–139 as a substrate and osteocalcin, PPi and phosphate as inhibitorsBiochemical Journal, 2001
- The Autosomal Dominant Hypophosphatemic Rickets (ADHR) Gene Is a Secreted Polypeptide Overexpressed by Tumors that Cause Phosphate WastingJournal of Clinical Endocrinology & Metabolism, 2001
- Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23Nature Genetics, 2000
- Tumor-induced osteomalacia and the regulation of phosphate homeostasisPublished by Elsevier ,2000
- PHEX gene and hypophosphatemiaKidney International, 2000